BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 28569372)

  • 1. Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?
    Bala A; Huddleston JI; Goodman SB; Maloney WJ; Amanatullah DF
    Clin Orthop Relat Res; 2017 Sep; 475(9):2205-2213. PubMed ID: 28569372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboprophylaxis after total hip arthroplasty: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?
    Bala A; Murasko MJ; Burk DR; Huddleston JI; Goodman SB; Maloney WJ; Amanatullah DF
    Hip Int; 2020 Sep; 30(5):564-571. PubMed ID: 30990095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
    Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
    J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin
    Goel R; Fleischman AN; Tan T; Sterbis E; Huang R; Higuera C; Parvizi J; Rothman RH
    Bone Joint J; 2018 Jan; 100-B(1 Supple A):68-75. PubMed ID: 29292343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are factor Xa inhibitors effective thromboprophylaxis following hip fracture surgery?: A large national database study.
    Campbell ST; Bala A; Jiang SY; Gardner MJ; Bishop JA
    Injury; 2017 Dec; 48(12):2768-2772. PubMed ID: 29102371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
    J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pharmacologic prophylaxis in prevention of venous thromboembolism following total knee arthroplasty.
    Richardson SS; Schairer WW; Sculco PK; Bostrom MP
    Knee; 2019 Mar; 26(2):451-458. PubMed ID: 30700390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial.
    ; Sidhu VS; Kelly TL; Pratt N; Graves SE; Buchbinder R; Adie S; Cashman K; Ackerman I; Bastiras D; Brighton R; Burns AWR; Chong BH; Clavisi O; Cripps M; Dekkers M; de Steiger R; Dixon M; Ellis A; Griffith EC; Hale D; Hansen A; Harris A; Hau R; Horsley M; James D; Khorshid O; Kuo L; Lewis P; Lieu D; Lorimer M; MacDessi S; McCombe P; McDougall C; Mulford J; Naylor JM; Page RS; Radovanovic J; Solomon M; Sorial R; Summersell P; Tran P; Walter WL; Webb S; Wilson C; Wysocki D; Harris IA
    JAMA; 2022 Aug; 328(8):719-727. PubMed ID: 35997730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.
    Bawa H; Weick JW; Dirschl DR; Luu HH
    J Am Acad Orthop Surg; 2018 Oct; 26(19):698-705. PubMed ID: 30153117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
    PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
    Ma G; Zhang R; Wu X; Wang D; Ying K
    Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
    Deirmengian GK; Heller S; Smith EB; Maltenfort M; Chen AF; Parvizi J
    J Arthroplasty; 2016 Oct; 31(10):2237-40. PubMed ID: 27118182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single-centre, single-surgeon, retrospective analysis.
    King DA; Pow RE; Dickison DM; Vale PR
    Intern Med J; 2016 Sep; 46(9):1030-7. PubMed ID: 27246450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prophylaxis Following Total Knee Arthroplasty.
    Faour M; Piuzzi NS; Brigati DP; Klika AK; Mont MA; Barsoum WK; Higuera CA
    J Arthroplasty; 2018 Jul; 33(7S):S131-S135. PubMed ID: 29656974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative Blood Transfusions Are Associated with a Higher Incidence of Thromboembolic Events After TKA: An Analysis of 333,463 TKAs.
    Acuña AJ; Grits D; Samuel LT; Emara AK; Kamath AF
    Clin Orthop Relat Res; 2021 Mar; 479(3):589-600. PubMed ID: 33165044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin for Venous Thromboembolic Prophylaxis Following Total Hip and Total Knee Arthroplasty: An Analysis of Safety and Efficacy Accounting for Surgeon Selection Bias.
    Heckmann ND; Piple AS; Wang JC; Richardson MK; Mayfield CK; Oakes DA; Christ AB; Lieberman JR
    J Arthroplasty; 2023 Jul; 38(7 Suppl 2):S412-S419.e1. PubMed ID: 36870517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboprophylaxis after minimally invasive total knee arthroplasty: a comparison of rivaroxaban and enoxaparin.
    Yen SH; Lin PC; Kuo FC; Wang JW
    Biomed J; 2014; 37(4):199-204. PubMed ID: 25116715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Incidence of Bleeding and Wound Complications With Factor-Xa Inhibitors After Total Joint Arthroplasty.
    Garfinkel JH; Gladnick BP; Roland N; Romness DW
    J Arthroplasty; 2018 Feb; 33(2):533-536. PubMed ID: 28947374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.